Brief Virtual Mindfulness-based Group Intervention With Social Support for Perinatal Individuals
CPO Pilot: Brief Virtual Mindfulness Based Group Intervention With Social Support
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Olivia J Doyle, BA
- Phone Number: 503-933-0608
- Email: doyleo@ohsu.edu
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health and Science University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Currently pregnant
- Have a single gestation pregnancy
- Fluently speak English
- A history of significant substance use or currently in treatment for a substance use disorder.
Exclusion Criteria:
- Inability to provide consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Virtual Mindfullness-Based Support Group
The virtual mindfulness-based intervention with social support groups will meet once a week for 4 weeks, each session will be 60 minutes.
Each group will have 3-8 participants.
The groups will be closed, meaning the same group of participants meet with the same instructor (unless a backup instructor is needed due to unavoidable reasons).
Groups will be completed using the video conferencing application.
|
Virtual administration of the social support components of an adapted 4-week Mindfulness Based Cognitive Therapy for Postpartum Depression (MBCT-PD) intervention.
Each session includes a review of assigned online mindfulness practice and barriers to practice, other homework if also assigned, psychoeducation, and mindfulness practices relevant to the session's theme.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility - Interest
Time Frame: at 1 week
|
the number of individuals interested in participation.
|
at 1 week
|
|
Feasibility - Attendance
Time Frame: up to 2 months
|
the number of individuals who attend group and the average number of groups attended.
|
up to 2 months
|
|
Acceptability
Time Frame: up to 2 months
|
Acceptability will be assessed using the Customer Satisfaction Questionnaires (CSQ-8).
Scores range from 8-32 with higher scores indicating higher satisfaction.
|
up to 2 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pregnancy-specific stress
Time Frame: up to 2 months
|
Pregnancy-specific stress will be measured using and the Prenatal Distress Questionnaire (PDQ).
Scores range from 0 to 46 with higher scores indicating higher distress.
|
up to 2 months
|
|
Psychological Distress
Time Frame: up to 2 months
|
Overall psychological distress will be measured using the Center for Epidemiological Studies Depression - Revised (CESD-R).
Scores range from 0 to 60 with higher scores indicating more severe depressive symptomatology.
|
up to 2 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Kristen Mackiewicz Seghete, PhD, Oregon Health and Science University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- STUDY00022406
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.